9H-9-fluorenylmethyl N-[4-(4-amino-2-butyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)butyl]carbamate | 227318-98-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 芴
• 英文名称: 9H-9-fluorenylmethyl N-[4-(4-amino-2-butyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)butyl]carbamate
• 英文别名: 9H-fluoren-9-ylmethyl N-[4-(4-amino-2-butylimidazo[4,5-c][1,5]naphthyridin-1-yl)butyl]carbamate
• CAS: 227318-98-1
• 化学式: C₃₂H₃₄N₆O₂
• 分子量: 534.661
• InChiKey: FYMYHJWHCPGNMD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  40
• 可旋转键数：
  11
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  108
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-(4-amino-2-butyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)butaneamine 、 氯甲酸-9-芴基甲酯 以to provide 0.125 g of 9H-9-fluorenylmethyl N-[4-(4-amino-2-butyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)butyl]carbamate as a white powder的产率得到9H-9-fluorenylmethyl N-[4-(4-amino-2-butyl-1H-imidazo[4,5-c][1,5]naphthyridin-1-yl)butyl]carbamate
  参考文献：
  名称：

  Imidazonaphtyridines

  摘要：

  Imidazonaphthyridine和tetrahydroimidazonaphthyridine化合物可以诱导干扰素和肿瘤坏死因子等细胞因子的生物合成。这些化合物具有抗病毒和抗肿瘤的性质。本文还公开了制备这些化合物和制备这些化合物的中间体的方法。

  公开号：

  US20030096998A1

文献信息

• Imidazonaphthyridines
  申请人：3M Innovative Properties Company

  公开号：US06194425B1

  公开（公告）日：2001-02-27

  Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

  咪唑并噻吩并噻吩衍生物和四氢咪唑并噻吩衍生物诱导细胞因子的生物合成，例如干扰素和肿瘤坏死因子。这些化合物具有抗病毒和抗肿瘤特性。还公开了制备这些化合物以及在制备这些化合物中有用的中间体的方法。
• [EN] IMIDAZONAPHTHYRIDINES AND THEIR USE IN INDUCING CYTOKINE BIOSYNTHESIS<br/>[FR] IMIDAZONAPHTHYRIDINES ET LEUR UTILISATION DANS L'ACTIVATION DE LA BIOSYNTHESE DE CYTOKINES
  申请人：MINNESOTA MINING & MFG

  公开号：WO1999029693A1

  公开（公告）日：1999-06-17

  Imidazonaphthyridine (I) and tetrahydroimidazonaphthyridine (II) compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed. R1 and R2 and A are as defined in the application.

  Imidazonaphthyridine (I) 和tetrahydroimidazonaphthyridine (II) 化合物能够诱导细胞因子如干扰素和肿瘤坏死因子的生物合成。这些化合物具有抗病毒和抗肿瘤的特性。本发明还公开了制备这些化合物和制备这些化合物中间体的方法。其中R1、R2和A的定义如申请书中所述。
• INTERMEDIATES FOR IMIDAZONAPHTHYRIDINES
  申请人：Gerster F. John

  公开号：US20060128674A1

  公开（公告）日：2006-06-15

  Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.

  Imidazonaphthyridine和tetrahydroimidazonaphthyridine化合物可以诱导干扰素和肿瘤坏死因子等细胞因子的生物合成。这些化合物具有抗病毒和抗肿瘤的特性。该专利公开了制备这些化合物及其中间体的方法。
• IMIDAZONAPHTHYRIDINES
  申请人：Gerster F. John

  公开号：US20050288320A1

  公开（公告）日：2005-12-29

  Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

  Imidazonaphthyridine和tetrahydroimidazonaphthyridine化合物会诱导干扰素和肿瘤坏死因子等细胞因子的生物合成。这些化合物具有抗病毒和抗肿瘤的性质。本发明还揭示了制备这些化合物以及制备这些化合物中间体的方法。
• Imidazonaphtyridines
  申请人：3M Innovative Properties Company

  公开号：US20030096998A1

  公开（公告）日：2003-05-22

  Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

  Imidazonaphthyridine和tetrahydroimidazonaphthyridine化合物可以诱导干扰素和肿瘤坏死因子等细胞因子的生物合成。这些化合物具有抗病毒和抗肿瘤的性质。本文还公开了制备这些化合物和制备这些化合物的中间体的方法。